Patients on Biologics for Severe Asthma Show Reduced Response to SARS-CoV-2 Vaccination
October 18th 2022Martin Runnström, MD, a fourth-year fellow at the Emory University School of Medicine, describes a study he presented at CHEST 2022 showing a reduced response to a 2-dose immunization series for SARS-CoV-2 among patients using biologics to treat severe asthma or atopic dermatitis.
Watch
Experts anticipate a rise in US COVID-19 cases, hospitalizations, and deaths beginning in 3 to 4 weeks; Covis Pharma pushes to keep hydroxyprogesterone caproate (Makena) on the market; more than 1.3 million American adults with diabetes delayed purchasing or skipped or rationed insulin doses due to high costs.
Read More
Returning to a Humanistic Approach of Preventing Delirium in the ICU
October 18th 2022In the Roger C. Bone Memorial Lecture in Critical Care at CHEST 2022, E. Wesley Ely, MD, MPH, of the Vanderbilt University School of Medicine, highlights the need for humanism in the intensive care unit and how the COVID-19 pandemic destroyed what had been built up.
Read More
Exploring Strategies for Timely Diagnosis, Comprehensive Care in Hidradenitis Suppurativa
October 18th 2022Researchers reviewed clinical features of hidradenitis suppurativa and provided strategies to promote earlier identification, differentiation from common mimickers, and timely referrals for multidisciplinary management.
Read More
Patients With Asthma, Other Allergic Diseases May Have Higher Prevalence of EoE
October 18th 2022While the prevalence of eosinophilic esophagitis (EoE) is estimated to be 0.5% in the general population, a recent study found that the prevalence was as high as 16.5% in patients with allergic disease.
Read More
Level of QOL Impact of Psoriasis Does Not Appear to Be Influenced by Affected Body Region
October 18th 2022Prior to the analysis, researchers hypothesized that having localized psoriasis on more visible and/or more sensitive areas, including the face and genitals, would yield a more significant impact on quality of life.
Read More
Dr Basil Kahwash on the Comorbidity With the Greatest Impact on Asthma Outcomes
October 17th 2022Some atopic diseases affect asthma outcomes more than others, said Basil Kahwash, MD, an assistant professor of medicine on the clinical educator track in the Department of Medicine at Vanderbilt University Medical Center, who spoke at CHEST 2022.
Watch
A digitally delivered targeted intervention of symptom and trigger education, treatment reminders, lifestyle coaching, and healthy lifestyle support demonstrated significant improvements in treatment adherence and related clinical outcomes among Icelandic patients with atopic dermatitis.
Read More
The Bill and Melinda Gates Foundation donated $1.2 billion toward eradicating polio worldwide; founders of BioNTech say that cancer vaccines could be available within the next decade; an early increase in flu activity has hit southeast and south-central states hardest according to the CDC.
Read More
Pulmonary Embolism Treatments Are Evolving, Says Dr Parth Rali
October 16th 2022There are several closely watched randomized trials examining catheter-directed therapies for acute pulmonary embolism, according to Parth Rali, MD, an associate professor of thoracic medicine and surgery at the Lewis Katz School of Medicine and director of the Temple University Health System Pulmonary Embolism Response Team.
Watch
Patients With Uncontrolled Asthma May Need to Be Considered for Triple Therapy, Posters Find
October 16th 2022One poster found patients with uncontrolled asthma had improved outcomes after escalating to triple therapy, while the other found a substantial portion of patients adherent to a dual therapy reported not having controlled asthma.
Read More
Dr Kara Dupuy-McCauley Discusses Obesity and Response to Viruses, Vaccines
October 16th 2022While more research is needed, obesity does play a role in the response to viral infections as well as immunizations, said Kara Dupuy-McCauley, MD, a pulmonologist at the Mayo Clinic in Rochester, Minnesota.
Watch
Addressing Disparities Starts With Rebuilding Trust, Connecting Better With Patients
October 16th 2022The first 5 minutes of a patient’s visit with a doctor can help improve communication and build more trusting relationships, explained panelists during a session on lung health disparities in America at CHEST 2022.
Read More
Researchers Highlight Importance of Assessing Osteoporosis Risk Factors in RA
October 15th 2022Risk of osteoporosis and bone fractures in rheumatoid arthritis (RA) stem from disease-specific causes, disease treatment, and factors that face the general population, according to researchers, who highlighted the importance of assessing risk factors in these patients.
Read More
Stem Cells Highlighted as Potential Therapeutic Option in Huntington Disease
October 15th 2022Although no pharmacological treatment offers long-term efficacy or extends survival with Huntington disease at this point, research suggests that stem-cell therapy holds promise in this and other neurodegenerative diseases.
Read More
Dr Melissa O'Connor Discusses Impact of SDOH on Older Adults, Home Health Outcomes
October 15th 2022Melissa O'Connor, PhD, MBA, RN, FGSA, FAAN, endowed professor in community and home health nursing, M. Louise Fitzpatrick School of Nursing, Villanova University, and director, Gerontology Interest Group, addressed the impact of food/housing insecurity and other social determinants of health (SDOH) on care outcomes in home health.
Watch
Dr Tam Phan Highlights Positive Impact Pharmacists Can Have on Transgender, Nonbinary Patients
October 15th 2022Tam C. Phan, PharmD, AAHIVP, assistant professor of clinical pharmacy, USC School of Pharmacy, explains why it's important for pharmacists to learn about and advocate for their patients who are transgender or gender nonbinary.
Watch
Review Underscores Potential and Obstacles of Universal CAR T-Cell Therapy
October 15th 2022Despite the obstacles and risks, the review authors conclude that universal chimeric antigen receptor (CAR) T-cell therapy has the potential to play a key role and mitigate some of the limitations associated with autologous CAR T-cell therapy in cancer treatment.
Read More
Payers Need Enhanced Utilization Management to Optimize High-Cost Therapies, Panel Says
October 15th 2022Panelists at an Academy of Managed Care Pharmacy (AMCP) Nexus 2022 session discussed enhanced utilization management strategies to manage the rising cost of specialty drugs, while providing members with support for rare, complex conditions.
Read More